Table 2.

Neutrophil subsets (average %) by cohort of Visit 1 and Visit 2

Cohort
Neutrophil subset	Poorly-controlled diabetes mellitus (N = 14)	Well-controlled diabetes mellitus (N = 12)	Morbid obesity (N = 12)	Obese with metabolic syndrome (N = 20)	Obese without metabolic syndrome (N = 20)	Control (N = 12)
“Normal” (CD16^bright/CD62L^bright)
N, % RSD	14, 3.73	12, 7.54	12, 18.10	20, 9.11	20, 16.83	12, 6.85
Mean, median	91.2, 92.3	90.3, 91.9	81.1, 84.0	86.3, 88.4	84.0, 89.9	88.5, 89.0
95% CI	84.2, 98.9	76.5, 106.5	54.7, 120.5	71.3, 104.4	59.2, 119.2	76.1, 102.9
“Suppressors” (CD16^bright/CD62L^dim)
N, % RSD	14, 107.5	12, 135.3	12, 150.9	20, 143.6	20, 213.2	12, 124.2
Mean, median	2.5, 2.5	2.4, 2.2	5.9, 6.1	3.4, 3.2	4.2, 3.6	2.2, 1.5
95% CI	0.4, 16.9	0.3, 22.7	0.5, 65.1	0.4, 31.1	0.3, 65.1	0.3, 18.5
“Killer” (CD16^dim/CD62L^bright)
N, % RSD	14, 82.83	12, 83.71	12, 60.22	20, 78.80	20, 55.68	12, 43.27
Mean, median	2.8, 2.7	3.1, 3.1	4.9, 5.3	4.7, 5.1	3.0, 3.2	4.7, 4.9
95% CI	0.6, 13.3	0.6, 15.5	1.5, 16.8	1.1, 20.2	1.0, 8.9	1.9, 11.7
%CD47+
N, % RSD	14, 0.03	12, 0.44	12, 0.04	20, 0.23	20, 0.04	12, 0.01
Mean, median	100.0, 100.0	99.8, 100.0	100.0, 100.0	99.9, 100.0	100.0, 100.0	100.0, 100.0
95% CI	99.9, 100.0	98.8, 100.7	99.9, 100.1	99.4, 100.4	99.9, 100.1	100.0, 100.0
CD47 MFI
N, % RSD	14, 25.13	12, 48.26	12, 18.40	20, 17.28	20, 19.60	12, 19.80
Mean, median	18,462, 16,709	15,558, 16,598	19,060, 19,857	16,627, 17,062	17,226, 16,118	18,164, 17,718
95% CI	10,817, 31,510	5684, 42,590	12,757, 28,477	11,612, 23,809	11,475, 25,860	11,797, 27,967

CI confidence interval, MFI mean fluorescence intensity, RSD relative standard deviation